A crowd gathered at a Shanghai hospital, lining for remedies made with plant mixtures and animal parts including scorpions and freeze-dried millipedes — medicines that China hopes will find an audience overseas.
With a history going back 2,400 years, traditional Chinese medicine (TCM) is deeply rooted in the country and remains popular, despite access to Western pharmaceuticals.
The authorities are hoping to modernize and export the remedies, but they face major obstacles.
A veritable forest of medicinal plants surrounded patients waiting at Yueyang Hospital’s pharmacy. Some left with boxes of pills, others took away plastic sachets filled with herbal extracts.
Lin Hongguo, a 76-year-old pensioner, has bought herbal remedies that he would boil to make a tea to treat his “slow-beating heart.”
“I prefer it to Western medicines. It’s not about the cost, it’s because it works well,” he told reporters.
Another patient, pet fish seller Wang Deyun, 51, is also a believer.
“Two months ago my skin had an allergic reaction to a modern medicine for high blood pressure,” she said from her hospital bed.
However, after a treatment of facial masks and plant infusions, she said she is almost fully healed.
Traditional medicine is subsidized in China and is cheaper than Western medicine. It consistently makes up one quarter of the country’s pharmaceuticals market — even as China increasingly opens up to modern medicine.
The WHO is next year to include a chapter on traditional medicine in its “International Classification of Diseases” — a tome of reference for medical trends and global health statistics.
China hopes the WHO inclusion will spur global recognition of its traditional remedies as it seeks to export them.
However, Beijing still faces significant hurdles, not least the fact that TCM focuses on tailoring treatment to each individual, which means different people with the same condition can be prescribed different medicines and dosages.
“It’s like a painting — it’s composed differently each time, while Western medicine is more similar to photography” with its standardized products, said Wang Zhenyi, a proctologist at Yueyang Hospital.
That is the crux of China’s challenge in gaining overseas acceptance: Its traditional medicine is largely incompatible with modern clinical trials, which require an identical product to be tested on a large number of patients.
As these medicines typically contain dozens of ingredients, understanding how they work together and proving their effectiveness is a complex task.
Even within China there have been public skirmishes over the efficacy of TCM, pitting its proponents against doctors who advocate evidence-based, peer-reviewed medicine.
Conservationists have said that growing demand for products like rhino horn and pangolin scales — which are used by some practitioners even though they have no proven medical properties — have decimated vulnerable species.
China last month partially lifted a ban on trading tiger bones and rhino horns, despite warnings from conservationists, although state media later quoted an official as saying the change had been “postponed.”
Chinese experts have said endangered animal parts are increasingly being replaced by synthetic versions, but TCM might still prove a tough sell abroad.
“I think the best potential is in the consumer market, such as nutritional supplements,” said Tony Ren, a pharma analyst with Kim Eng Securities in Hong Kong.
Few Western pharmaceutical companies are keen to try to untangle these difficulties.
However, French biotech company Pharnext has taken on the challenge, partnering last year with Tasly, one of China’s biggest producers of traditional medicines.
Together, they are looking to transform the industry by streamlining “the procedures to have a more stable production of plants, which have identical properties, and understand why the mixture works,” Pharnext founder and chief executive officer Daniel Cohen said.
SEEKING CHANGE: A hospital worker said she did not vote in previous elections, but ‘now I can see that maybe my vote can change the system and the country’ Voting closed yesterday across the Solomon Islands in the south Pacific nation’s first general election since the government switched diplomatic allegiance from Taiwan to Beijing and struck a secret security pact that has raised fears of the Chinese navy gaining a foothold in the region. The Solomon Islands’ closer relationship with China and a troubled domestic economy weighed on voters’ minds as they cast their ballots. As many as 420,000 registered voters had their say across 50 national seats. For the first time, the national vote also coincided with elections for eight of the 10 local governments. Esther Maeluma cast her vote in the
Nearly half of China’s major cities are suffering “moderate to severe” levels of subsidence, putting millions of people at risk of flooding, especially as sea levels rise, according to a study of nationwide satellite data released yesterday. The authors of the paper, published by the journal Science, found that 45 percent of China’s urban land was sinking faster than 3mm per year, with 16 percent at more than 10mm per year, driven not only by declining water tables, but also the sheer weight of the built environment. With China’s urban population already in excess of 900 million people, “even a small portion
UNSETTLING IMAGES: The scene took place in front of TV crews covering the Trump trial, with a CNN anchor calling it an ‘emotional and unbelievably disturbing moment’ A man who doused himself in an accelerant and set himself on fire outside the courthouse where former US president Donald Trump is on trial has died, police said yesterday. The New York City Police Department (NYPD) said the man was declared dead by staff at an area hospital. The man was in Collect Pond Park at about 1:30pm on Friday when he took out pamphlets espousing conspiracy theories, tossed them around, then doused himself in an accelerant and set himself on fire, officials and witnesses said. A large number of police officers were nearby when it happened. Some officers and bystanders rushed
HYPOCRISY? The Chinese Ministry of Foreign Affairs yesterday asked whether Biden was talking about China or the US when he used the word ‘xenophobic’ US President Joe Biden on Wednesday called for a hike in steel tariffs on China, accusing Beijing of cheating as he spoke at a campaign event in Pennsylvania. Biden accused China of xenophobia, too, in a speech to union members in Pittsburgh. “They’re not competing, they’re cheating. They’re cheating and we’ve seen the damage here in America,” Biden said. Chinese steel companies “don’t need to worry about making a profit because the Chinese government is subsidizing them so heavily,” he said. Biden said he had called for the US Trade Representative to triple the tariff rates for Chinese steel and aluminum if Beijing was